Related Experiment Video
Updated: Mar 26, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Premalignancy in Prostate Cancer: Rethinking What we Know.
Angelo M De Marzo1, Michael C Haffner2, Tamara L Lotan3
1Departments of Pathology Oncology Urology The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center The Brady Urological Research Institute at Johns Hopkins, Johns Hopkins University, Baltimore, MD. ademarz@jhmi.edu.
High-grade prostatic intraepithelial neoplasia (PIN) may sometimes be invasive prostate cancer spread, not a precursor. Molecular pathology is needed to distinguish true PIN from cancer to improve clinical trial accuracy.
Area of Science:
- Urologic pathology
- Molecular pathology
- Cancer research
Background:
- High-grade prostatic intraepithelial neoplasia (PIN) is considered the primary precursor to prostate adenocarcinoma.
- However, some lesions diagnosed as high-grade PIN may represent intra-acinar or intraductal spread of invasive carcinoma.
- This overlap is supported by shared genomic alterations (e.g., TMPRSS2-ERG fusion) and molecular phenotypes between high-grade PIN and carcinoma.
Purpose of the Study:
- To address the diagnostic ambiguity between high-grade PIN and invasive prostate cancer spread.
- To highlight the need for molecular pathology to differentiate precursor lesions from intra-acinar/intraductal cancer.
- To improve the interpretation of clinical trials and reduce bias in patient selection.
Main Methods:
- Review of existing epidemiologic, molecular pathologic, and anatomic studies.
- Discussion of the potential for misclassification of high-grade PIN and intraductal carcinoma.
- Emphasis on the necessity for novel molecular approaches for accurate diagnosis.
Main Results:
- Lesions diagnosed as high-grade PIN can mimic intra-acinar or intraductal spread of invasive carcinoma.
- This potential misclassification can confound the interpretation of past clinical trials.
- Molecular markers like TMPRSS2-ERG fusion and PTEN loss show promise in distinguishing these entities.
Conclusions:
- Accurate differentiation of high-grade PIN from invasive cancer spread is crucial for reliable prostate cancer research and clinical trials.
- Novel molecular pathology techniques are essential to resolve diagnostic uncertainties.
- Improved classification of high-grade PIN and intraductal carcinoma will enhance patient stratification and therapeutic strategies.
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
06:08A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation